{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T14:05:14Z","timestamp":1789740314438,"version":"4.0.1"},"reference-count":33,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"9","license":[{"start":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:00:00Z","timestamp":1789689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trans. Vis. Sci. Tech."],"published-print":{"date-parts":[[2026,9,18]]},"DOI":"10.1167\/tvst.15.9.8","type":"journal-article","created":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:30:41Z","timestamp":1789738241000},"page":"8","source":"Crossref","is-referenced-by-count":0,"title":["Choroidal Vascular Remodeling After Loading Injections of Faricimab in Diabetic Macular Edema"],"prefix":"10.1167","volume":"15","author":[{"given":"Jounghan","family":"Kim","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye Eun","family":"Han","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Jeon","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyeop","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea"},{"name":"Graduate School of Health Science and Technology, UNIST, Ulsan, South Korea"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"3","key":"bib1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"13","key":"bib2","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa1414264","article-title":"Aflibercept, bevacizumab, or ranibizumab for diabetic macular edema","volume":"372","author":"Wells","year":"2015","journal-title":"N Engl J Med"},{"issue":"9","key":"bib3","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1001\/jamaophthalmol.2020.2685","article-title":"Safety and efficacy of different doses and regimens of faricimab vs ranibizumab in neovascular age-related macular degeneration: the AVENUE phase 2 randomized clinical trial","volume":"138","author":"Sahni","year":"2020","journal-title":"JAMA Ophthalmol"},{"issue":"12","key":"bib4","doi-asserted-by":"publisher","first-page":"10167","DOI":"10.3390\/ijms241210167","article-title":"The role of diabetic choroidopathy in the pathogenesis and progression of diabetic retinopathy","volume":"24","author":"Scuderi","year":"2023","journal-title":"Int J Mol Sci"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.visres.2017.04.011","article-title":"Diabetic choroidopathy","volume":"139","author":"Lutty","year":"2017","journal-title":"Vision Res"},{"issue":"8","key":"bib6","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/biology10080725","article-title":"Quantitative assessment of choroidal parameters in patients with various types of diabetic macular oedema: a single-centre cross-sectional analysis","volume":"10","author":"Dmuchowska","year":"2021","journal-title":"Biology"},{"issue":"1","key":"bib7","first-page":"3033219","article-title":"Choroidal vascularity index as a biomarker for visual response to antivascular endothelial growth factor treatment in diabetic macular edema","volume":"2021","author":"Dou","year":"2021","journal-title":"J Diabetes Res"},{"issue":"1","key":"bib8","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci Rep"},{"issue":"2","key":"bib9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.3390\/jcm9020595","article-title":"Choroidal vascularity index: an in-depth analysis of this novel optical coherence tomography parameter","volume":"9","author":"Iovino","year":"2020","journal-title":"J Clin Med"},{"issue":"11","key":"bib10","doi-asserted-by":"publisher","first-page":"3203","DOI":"10.4103\/ijo.IJO_1585_21","article-title":"Validation of choroidal hyperreflective foci in diabetic macular edema through a retrospective pilot study","volume":"69","author":"Saurabh","year":"2021","journal-title":"Indian J Ophthalmol"},{"issue":"4","key":"bib11","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/APO.0000000000000249","article-title":"Choroidal hyperreflective foci: a novel spectral domain optical coherence tomography biomarker in eyes with diabetic macular edema","volume":"8","author":"Roy","year":"2019","journal-title":"Asia Pac J Ophthalmol"},{"issue":"1","key":"bib12","doi-asserted-by":"publisher","first-page":"e001295","DOI":"10.1136\/bmjdrc-2020-001295","article-title":"Decrease in choroidal vascularity index of Haller's layer in diabetic eyes precedes retinopathy","volume":"8","author":"Foo","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"2","key":"bib13","doi-asserted-by":"crossref","first-page":"122","DOI":"10.14744\/eer.2024.42275","article-title":"Vascular indexes of choroidal layers in diabetic macular edema","volume":"4","author":"Akmaz","year":"2024","journal-title":"European Eye Research"},{"issue":"1","key":"bib14","first-page":"5708354","article-title":"Comparison of the effect of ranibizumab and aflibercept on changes in macular choroidal thickness in patients treated for diabetic macular edema","volume":"2020","author":"Sarda","year":"2020","journal-title":"J Ophthalmol"},{"issue":"1","key":"bib15","doi-asserted-by":"publisher","first-page":"348","DOI":"10.3390\/jcm12010348","article-title":"Influence of intravitreal therapy on choroidal thickness in patients with diabetic macular edema","volume":"12","author":"Udaondo Mirete","year":"2023","journal-title":"J Clin Med"},{"issue":"10","key":"bib16","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1007\/s00417-018-4072-z","article-title":"Choroidal thickness changes stratified by outcome in real-world treatment of diabetic macular edema","volume":"256","author":"Campos","year":"2018","journal-title":"Graefe Arch Clin Exp Ophthalmol"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40942-025-00777-z","article-title":"Analysis of correlations between biomarkers assessed with swept-source OCT and OCT angiography in na\u00efve patients with diabetic macular edema treated with aflibercept: a prospective study","volume":"12","author":"Rezende","year":"2026","journal-title":"Int J Retina Vitreous"},{"key":"bib18","doi-asserted-by":"publisher","first-page":"1682311","DOI":"10.3389\/fmed.2025.1682311","article-title":"Progress in the treatment of diabetic macular edema with faricimab: a review","volume":"12","author":"Gao","year":"2025","journal-title":"Front Med"},{"issue":"1","key":"bib19","first-page":"1485059","article-title":"Factors affecting intensive aflibercept treatment response in diabetic macular edema: a real-world study","volume":"2023","author":"Han","year":"2023","journal-title":"J Diabetes Res"},{"key":"bib20","doi-asserted-by":"publisher","first-page":"1108097","DOI":"10.3389\/fendo.2023.1108097","article-title":"A real-world study for timely assessing the diabetic macular edema refractory to intravitreal anti-VEGF treatment","volume":"14","author":"Hsieh","year":"2023","journal-title":"Front Endocrinol"},{"issue":"4","key":"bib21","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.ajo.2008.05.032","article-title":"Enhanced depth imaging spectral-domain optical coherence tomography","volume":"146","author":"Spaide","year":"2008","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"bib22","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1097\/IAE.0b013e3182993e09","article-title":"Analysis of the thickness and vascular layers of the choroid in eyes with geographic atrophy using spectral-domain optical coherence tomography","volume":"34","author":"Adhi","year":"2014","journal-title":"Retina"},{"issue":"9","key":"bib23","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1016\/j.ophtha.2013.01.066","article-title":"Analysis of choroidal morphologic features and vasculature in healthy eyes using spectral-domain optical coherence tomography","volume":"120","author":"Branchini","year":"2013","journal-title":"Ophthalmology"},{"issue":"4","key":"bib24","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1167\/iovs.12-11085","article-title":"Repeatability and reproducibility of choroidal vessel layer measurements in diabetic retinopathy using enhanced depth optical coherence tomography","volume":"54","author":"Sim","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"bib25","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1167\/iovs.14-14447","article-title":"Choroidal structure in normal eyes and after photodynamic therapy determined by binarization of optical coherence tomographic images","volume":"55","author":"Sonoda","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"2","key":"bib26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","article-title":"A guideline of selecting and reporting intraclass correlation coefficients for reliability research","volume":"15","author":"Koo","year":"2016","journal-title":"J Chiropr Med"},{"issue":"1","key":"bib27","doi-asserted-by":"publisher","first-page":"100111","DOI":"10.1016\/j.xops.2021.100111","article-title":"YOSEMITE and RHINE: phase 3 randomized clinical trials of faricimab for diabetic macular edema: study design and rationale","volume":"2","author":"Eter","year":"2022","journal-title":"Ophthalmol Sci"},{"issue":"8","key":"bib28","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.ophtha.2019.03.023","article-title":"Simultaneous inhibition of angiopoietin-2 and VEGF-A with faricimab in diabetic macular edema: BOULEVARD phase 2 randomized trial","volume":"126","author":"Sahni","year":"2019","journal-title":"Ophthalmology"},{"issue":"1","key":"bib29","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1038\/s41598-024-52315-w","article-title":"Choroidal remodeling following different anti-VEGF therapies in neovascular AMD","volume":"14","author":"Boscia","year":"2024","journal-title":"Sci Rep"},{"issue":"4","key":"bib30","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000458539","article-title":"Guidelines for the management of diabetic macular edema by the European Society of Retina Specialists (EURETINA)","volume":"237","author":"Schmidt-Erfurth","year":"2017","journal-title":"Ophthalmologica"},{"issue":"1","key":"bib31","doi-asserted-by":"publisher","first-page":"P66","DOI":"10.1016\/j.ophtha.2019.09.025","article-title":"Diabetic retinopathy preferred practice pattern\u00ae","volume":"127","author":"Flaxel","year":"2020","journal-title":"Ophthalmology"},{"issue":"7","key":"bib32","doi-asserted-by":"publisher","first-page":"736","DOI":"10.3109\/02713683.2013.867064","article-title":"Changes of choroidal thickness after treatment for diabetic retinopathy","volume":"39","author":"Lee","year":"2014","journal-title":"Curr Eye Res"},{"issue":"5","key":"bib33","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1097\/IAE.0000000000001645","article-title":"Changes in central choroidal thickness after treatment of diabetic macular edema with intravitreal bevacizumab correlation with central macular thickness and best-corrected visual acuity","volume":"38","author":"Nourinia","year":"2018","journal-title":"Retina"}],"container-title":["Translational Vision Science & Technology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.9.8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T13:30:42Z","timestamp":1789738242000},"score":1,"resource":{"primary":{"URL":"http:\/\/tvst.arvojournals.org\/article.aspx?doi=10.1167\/tvst.15.9.8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,18]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1167\/tvst.15.9.8","relation":{},"ISSN":["2164-2591"],"issn-type":[{"value":"2164-2591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,18]]}}}